Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Deal gives company access to potential schizophrenia blockbuster
Angry AHF brands company "heartless"
Potential Herceptin rival could have peak sales in excess of $3bn
Byetta shows advantages over insulin in type II diabetes
Reports of a rival bidder in the $2.6bn deal are discounted
But further research recommended for specific patient subgroups
ABPI welcomes government caution on adoption of OFT's recommendations
New indication could give further boost to potential blockbuster breast cancer drug
Orphan epiliepsy drug should be on market by June
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches